Review
doi: 10.1016/j.coph.2004.09.001.
11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action
Affiliations
- PMID: 15525550
- DOI: 10.1016/j.coph.2004.09.001
Item in Clipboard
Review
11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action
Curr Opin Pharmacol.
2004 Dec.
Abstract
11beta-hydroxysteroid dehydrogenases (11beta-HSDs) catalyse the interconversion of active cortisol and inert cortisone. Two isozymes have been discovered, each with unique properties and powerful biological roles. 11beta-HSD2 potently inactivates cortisol, protecting key tissues. By contrast, 11beta-HSD1 regenerates cortisol, amplifying its actions in liver, fat and brain. Overexpression of this isozyme may contribute to the pathogenesis of the metabolic syndrome. Its inhibition is a potential therapeutic target for both metabolic and glucocorticoid-associated CNS disorders.
Similar articles
-
11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.J Endocrinol. 2005 Aug;186(2):251-71. doi: 10.1677/joe.1.06019. J Endocrinol. 2005. PMID: 16079253 Review.
-
Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.J Allergy Clin Immunol. 2014 Oct;134(4):926-934.e6. doi: 10.1016/j.jaci.2014.03.033. Epub 2014 May 5. J Allergy Clin Immunol. 2014. PMID: 24810847
-
Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.Mol Cell Endocrinol. 2009 Mar 25;301(1-2):104-8. doi: 10.1016/j.mce.2008.10.030. Epub 2008 Oct 31. Mol Cell Endocrinol. 2009. PMID: 19022342
-
Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.Mol Cell Endocrinol. 2008 Mar 26;285(1-2):10-8. doi: 10.1016/j.mce.2008.01.012. Epub 2008 Feb 2. Mol Cell Endocrinol. 2008. PMID: 18313835
-
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.Drug Discov Today. 2007 Jul;12(13-14):504-20. doi: 10.1016/j.drudis.2007.06.001. Epub 2007 Jun 27. Drug Discov Today. 2007. PMID: 17631244 Review.
Cited by
-
Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.Semin Arthritis Rheum. 2019 Oct;49(2):251-259. doi: 10.1016/j.semarthrit.2019.03.010. Epub 2019 Mar 16. Semin Arthritis Rheum. 2019. PMID: 30987856 Free PMC article. Review.
-
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy.Heart Fail Rev. 2022 Jul;27(4):1431-1441. doi: 10.1007/s10741-021-10158-x. Epub 2021 Aug 28. Heart Fail Rev. 2022. PMID: 34455516 Review.
-
Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation.Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):423-8. doi: 10.1097/MCO.0b013e32833a5107. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20473154 Free PMC article. Review.
-
Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.J Steroid Biochem Mol Biol. 2013 Sep;137:82-92. doi: 10.1016/j.jsbmb.2013.02.002. Epub 2013 Feb 19. J Steroid Biochem Mol Biol. 2013. PMID: 23435016 Free PMC article. Review.
-
Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors.Int J Mol Sci. 2018 Jul 28;19(8):2210. doi: 10.3390/ijms19082210. Int J Mol Sci. 2018. PMID: 30060580 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
